Evidence map›Paper›PMID 39897352›Full record

ReviewVeterinary world2024

One Health initiative in India: Genesis and hurdles in establishing the first consortium.

Nagendra R Hegde, Malathi Talari, Subeer S Majumdar

Abstract readReview
In one paragraph

Review in Veterinary world, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Nagendra R HegdeBiotechnology Research and Innovation Council-National Institute of Animal Biotechnology, Hyderabad, Telangana, India.
Malathi TalariBiotechnology Research and Innovation Council-National Institute of Animal Biotechnology, Hyderabad, Telangana, India.
Subeer S MajumdarBiotechnology Research and Innovation Council-National Institute of Animal Biotechnology, Hyderabad, Telangana, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There are several challenges in implementing a meaningful One Health program. These include (a) understanding the language, intricacies, idiosyncrasies, and outcome indicators for each sector in multi-sectoral collaborations, (b) requirement of each partner to be trained outside their area of expertise, (c) absence of analysis of economics and long-term benefits, (d) complexities of the coordination and hand-holding of the various partners, and (e) uninterrupted financing of large consortia. There is, however, a clear understanding of the need for a team effort to support sustainable and progressive development. To achieve such an effort in India, the Department of Biotechnology (DBT), Ministry of Science and Technology, through prolonged deliberation, initiated a One Health project to understand the pervasiveness of the ten most critical zoonotic diseases through a nationwide study of the prevalence of these diseases in animals and to estimate the burden of the same diseases in clinical syndromes encountered in hospital settings. At the end of the project, we hope to map the spread and potential hotspots of the various diseases studied to undertake further collaborative studies focusing on diseases specific to particular geographic locations in the future. This review outlines the One Health initiatives in India and describes the difficulties in implementing the DBT One Health Consortium project.

Indexed as

One Healthtransboundary animal diseaseszoonoses

Identifiers

PMID39897352
PMCPMC11784042

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.